Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Navigo Proteins GmbH logo — Unique Affinity Solutions for Biopharmaceutical Manufacturin...

Navigo Proteins GmbH

Unique Affinity Solutions for Biopharmaceutical Manufacturing and Biotherapeutics

Founded 2017 Germany Germany 43 employees Biotechnology, Pharmaceutical

General Information

Company Name Navigo Proteins GmbH
Founded Year 2017
Location Germany Germany +1
Employees 43
Industries Biotechnology, Pharmaceutical
Social

Get notified when Navigo Proteins GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Navigo Proteins GmbH

Navigo Proteins GmbH is a biotech startup based in Germany, founded in 2017, specializing in the discovery and development of novel scaffold proteins-based affinity ligands for biopharmaceutical manufacturing and biotherapeutics. The company's unique protein engineering expertise has resulted in the establishment of a versatile scaffold proteins platform, allowing for the rapid design, production, analysis, and selection of suitable affinity ligand proteins optimized for industrial downstream processing or as biopharmaceutical drugs. The company's Precision Capturing technology utilizes a protein A-like scaffold to enable an antibody-like capture step, even for non-Fc bearing molecules, offering competitive binding capacities, caustic stabilities, usage cycles, flow rates, and commercially available off-the-shelf leaching assays. This technology is applicable for purifying various biologics such as recombinant proteins, monoclonal antibodies, viruses, VLPs, and cells. Furthermore, Precision Targeting platform creates tailored ligands that bind to any desired biologic, facilitating applications in biopharmaceuticals, diagnostics, radiopharmaceuticals, protein-drug-conjugates, CAR-T ligands, theranostics, and treatment monitoring. Navigo Proteins has garnered global partnerships to convert their custom affinity ligands into ready-to-use, GMP-compliant affinity resins for commercial downstream processing, further establishing their presence in the biopharmaceutical and life sciences industry. With approximately 50 employees and a continuous growth trajectory, Navigo Proteins offers its expertise to interested pharma, biotech, and life sciences companies, positioning itself as a significant player in the biotechnology and pharmaceutical sectors.

Taxonomy: protein engineering, affinity ligands, biopharmaceuticals, scaffold proteins, precision medicine, downstream processing, biologics purification, high-throughput platform, robotics, proprietary technology, GMP purification, biopharmaceutical drugs, affinity chromatography, precision capturing, modular platform

No funding data available for Navigo Proteins GmbH yet.

Get notified when Navigo Proteins GmbH raises funding

FAQ About Navigo Proteins GmbH

Unique Affinity Solutions for Biopharmaceutical Manufacturing and Biotherapeutics
Navigo Proteins GmbH was founded in 2017.
Navigo Proteins GmbH is headquartered in Germany.
Navigo Proteins GmbH operates in the following industries: Biotechnology, Pharmaceutical.
Navigo Proteins GmbH has approximately 43 employees.

We're actively collecting intelligence on Navigo Proteins GmbH.

Track Navigo Proteins GmbH to get notified

Don't just browse. Track.

Signal Tracker monitors Navigo Proteins GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy